CRT-D therapy in heart failure: How much do NYHA class IV patients benefit?

Journal of Cardiovascular Electrophysiology

Volumn 17, Issue 5, 2006, Pages 491-494

  Lehmann, Michael H ^a,b   Aaronson, Keith D ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT;

CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DEFIBRILLATOR; DEVICE; DISEASE CLASSIFICATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HIGH RISK POPULATION; HUMAN; MORTALITY; NEW YORK HEART ASSOCIATION FUNCTIONAL CLASS; NOTE; PREDICTION; PRIMARY PREVENTION; PRIORITY JOURNAL; QRS COMPLEX; RANDOMIZED CONTROLLED TRIAL; SUDDEN DEATH; SURVIVAL RATE; SYMPTOMATOLOGY; TREATMENT INDICATION;

AGED; ARRHYTHMIA; CARDIAC PACING, ARTIFICIAL; COMORBIDITY; DEFIBRILLATORS, IMPLANTABLE; DISEASE-FREE SURVIVAL; DOUBLE-BLIND METHOD; ELECTRIC COUNTERSHOCK; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 33645961013     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2006.00478.x     Document Type: Note

References (30)

1. DEFIBRILAT Study Group Actuarial risk of sudden death while awaiting cardiac transplantation in patients with atherosclerotic heart disease. Am J Cardiol 1991 68 545 546.
2. MERIT-HF Study Group Effect of Metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF). Lancet 1999 353 2001 2007.
3. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997 337 1576 1583.
4. Moss AJ Hall J Cannom DS Daubert JP Higgins SL Klein H Levine JH Saksena S Waldo AL Wilbe r D Brown MW Heo M for the Multicenter Automatic Defibrillator Implantation Trial Investigators Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996 326 1933 1940.
5. Curtis AB Cannom DS Bigger T DiMarco JP Estes NAM Steinman RC Parides MK Baseline characteristics of patients in the coronary artery bypass graft (CABG) patch trial. Am Heart J 1997 133 787 798.
6. Buxton AE Lee KL Fisher JD Josephson ME Prystowsky EN Hafley G for the Multicenter Unsustained Tachycardia Trail Investigators A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med 1999 341 1882 1890.
7. Moss AJ Zareba W Hall J Klein H Wilber DJ Cannom DS Daubert JP Higgins SL Brown MW Andrews ML for the Multicenter Automatic Defibrillator Implantation Trial II Investigators Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002 346 877 883.
8. Kadish A Dyer A Daubert JP Quigg R Estes M Anderson KP Calkins H Hoch D Goldberger J Shalaby A Sanders WE Schaechter A Levine JH for the Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators Prophylactic defibrillator implantation in patients with non-ischemic dilated cardiomyopathy. N Engl J Med 2004 350 2151 2158.
9. Bardy GH Lee KL Mark DB Poole JE Packer DL Boineau R Domanski M Troutman C Anderson J Johnson G McNulty SE Clapp-Channing N Davidson-Ray LK Fraulo ES Fishbein DP Luceri RM Ip HJ for the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005 352 225 237.
10. Abraham WT Fisher WG Smith AL Delurgio DB Leon AR Loh E Kocovic DZ Packer M Clavell AL Hayes DL Ellestad M Messenger J for the MIRACLE Study Group Cardiac resynchronization in chronic heart failure. N Engl J Med 2002 346 1845 1853.
11. Linde C Leclercq C Rex S Garrigue S Lavergne T Cazeau S McKenna W Fitzgerald M Deharo JC Alonso C Walker S Braunschweig F Bailleul C Daubert JC on behalf of the MUltisite STimulation In Cardiomyopathy (MUSTIC) Study Group Long-term benefits of biventricular pacing in congestive heart failure: Results from the MUltisite STimulation In Cardiomyopathy (MUSTIC) Study. J Am Coll Cardiol 2002 40 111 118.
12. Young JB Abraham WT Smith AL Leon AR Lieberman R Wilkoff B Canby RC Schroeder JS Liem LB Hall S Wheelan K for the Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE ICD) Trial Investigators Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: The MIRACLE ICD trial. JAMA 2003 289 2685 2694.
13. Higgins SL Hummel JD Niazi IK Giudici MC Worley SJ Saxon LA Boehmer JP Higginbotham MB De Marco T Foster E Yong PG Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular tachyarrhythmias. J Am Coll Cardiol 2003 42 1454 1459.
14. Bristow MR Saxon LA Boehmer J Krueger S Kass DA De Marco T Carson P DiCarlo L DeMets D White BG DeVries DW Feldman AM for the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004 350 2140 2150.
15. Cleland JGF Daubert JC Erdmann E Freemantle N Gras D Kappenberger L Tavazzi L for the Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators The effect of cardiac resynchronization on morbidity in heart failure. N Engl J Med 2005 352 1539 1549.
16. Desai AD Burke MC Hong TE Kim S Salem Y Yong PG Knight BP Predictors of appropriate defibrillator therapy among patients with an implantable defibrillator that delivers cardiac resynchronization therapy. J Cardiovasc Electrophysiol 2006 doi
17. Uretsky BF Sheahan RG Primary prevention of sudden cardiac death in heart failure: Will the solution be shocking? J Am Coll Cardiol 1997 30 1589 1597.
18. Wathen MS Degroot PJ Sweeney MO Stark AJ Otterness MF Adkisson WO Canby RC Khalighi K Machado C Rubenstein DS Volosin KJ for the PainFREE Rx II Investigators Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous implantable cardioverter-defibrillators: Pacing fast ventricular tachycardia reduces shock therapies (PainFREE Rx II) trial results. Circulation 2004 110 2591 2596.
19. Ellenbogen KA Levine JH Berger RD Daubert JP Winters SL Greenstein E Shalaby A Schaechter A Subacius H Kadish A for the Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy? Circulation 2006 113 776 782.
20. Saxon LA Wiener I DeLurgio DB Natterson PD Laks H Drinkwater DC Stevenson WG Implantable defibrillators for high-risk patients with heart failure who are awaiting cardiac transplantation. Am Heart J 1995 130 501 506.
21. Saba S Atiga WL Barrington W Ganz LI Kormos RL MacGowan GA Mathier MA McNamara DM Obioha-Ngwu O Murali S Selected patients listed for cardiac transplantation may benefit from defibrillator implantation regardless of an established indication. J Heart Lung Transplant 2003 22 411 418.
22. Sandner SE Wieselthaler G Zuckermann A Taghavi S Schmidinger H Pacher R Ploner M Laufer G Wolner E Grimm M Survival benefit of the implantable cardioverter-defibrillator in patients on the waiting list for cardiac transplantation. Circulation 2001 104 Suppl I I171 I176.
23. Singh SN Fletcher RD Fisher SG Singh BN Lewis HD Deedwania PC Massie BM Colling C Lazzeri D for the Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. N Engl J Med 1995 333 77 82.
24. Iuliano S Fisher SG Karasik PE Fletcher RD Singh SN for the Department of Veterans Affairs Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure QRS duration and mortality in patients with congestive heart failure. Am Heart J 2002 143 1085 1091.
25. Lecoq G Leclercq C Leray E Crocq C Alonso C de Place C Mabo P Daubert C Clinical and electrocardiographic predictors of a positive response to cardiac resynchronization therapy in advanced heart failure. Eur Heart J 2005 26 1094 1100.
26. Molhoek SG Bax JJ Bleeker GB Holman ER Van Erven L Bootsma M Boersma E Steendijk P Van Der Wall EE Schalij MJ Long-term follow-up of cardiac resynchronization therapy in patients with end-stage heart failure. J Cardiovasc Electrophysiol 2005 16 701 707.
27. Higgins SL Yong P Scheck D McDaniel M Bollinger F Vadecha M Desai S Meyer DB for the Ventak CHF Investigators Biventricular pacing diminishes the need for implantable cardioverter defibrillator therapy. J Am Coll Cardiol 2000 36 824 827.
28. Arya A Haghjoo M Dehghani MR Alasti M Alizadeh H Kazemi B Sadr-Ameli MA Effect of cardiac resynchronization therapy on the incidence of ventricular arrhythmias in patients with an implantable cardioverter-defibrillator. Heart Rhythm 2005 2 1094 1098.
29. Bleeker GB Schalij MJ Molhoek SG Verwey H Holman ER Boersma E Steendijk P Vander Wall EE Bax JJ Relationship between QRS duration and left ventricular dyssynchrony in patients with end-stage heart failure. J Cardiovasc Electrophysiol 2004 15 544 549.
30. Feldman AM de Lissovoy G Bristow MR Saxon LA De Marco T Kass DA Boehmer J Singh S Whellan DJ Carson P Boscoe A Baker TM Gunderman MR Cost effectiveness of cardiac resynchronization therapy in the comparison of medical therapy, pacing and defibrillation in heart failure (COMPANION) trial. J Am Coll Cardiol 2005 46 2311 2321.